Page last updated: 2024-10-22

amiodarone and Cancer of Stomach

amiodarone has been researched along with Cancer of Stomach in 2 studies

Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Huang, J1
Wen, F1
Huang, W1
Bai, Y1
Lu, X1
Shu, P1
Ozturk, MA1
Ozveren, O1
Cinar, V1
Erdik, B1
Oyan, B1

Reviews

1 review available for amiodarone and Cancer of Stomach

ArticleYear
Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemoth

2013

Other Studies

1 other study available for amiodarone and Cancer of Stomach

ArticleYear
Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis.
    Biomarkers in medicine, 2020, Volume: 14, Issue:12

    Topics: Amiodarone; Cell Cycle Proteins; Clomipramine; Collagen Type I; Databases, Genetic; Datasets as Topi

2020